Gowling WLG advised Eisai Co., Ltd. on the deal. Morgan Lewis advised Advanz Pharma. Eisai Co., Ltd. agreed to divest its rights for the antiepileptic agent…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
